www.latammastermind.com
Open in
urlscan Pro
2606:4700:10::6816:36fb
Public Scan
URL:
https://www.latammastermind.com/landing
Submission: On August 15 via manual from US — Scanned from DE
Submission: On August 15 via manual from US — Scanned from DE
Form analysis 0 forms found in the DOM
Text Content
* HOME * SPEAKERS * AGENDA * HOME * SPEAKERS * AGENDA DESAFÍOS DEL CÁNCER COLORRECTAL EN AMÉRICA LATINA Conversaremos acerca de la prevalencia e incidencia del cáncer colorrectal, los scorecards de políticas públicas y un kit de herramientas de políticas públicas Miércoles, 23 de agosto de 2023 10:00 a.m. – 11:45 a.m. EST (GMT -4) INGRESAR SPEAKERS Ana Rita González Policy Wisdom CEO Andrew Spiegel Global Colon Cancer Association (GCCA) CEO Nicole Sheahan Global Colon Cancer Association (GCCA) President Mia Masten Pfizer Sr. Director, Global Patient Advocacy Julieta D’Annunzio Pfizer Sr. Medical Director Colon Cancer & Melanoma for Emerging Markets Isabella Grueso Pfizer EM Oncology and I&I Public Affairs Lead AGENDA Tiempo Tema Speaker 20 min Bienvenida y Presentaciones Mia Masten & Isabella Grueso 20 min Situación Actual del Cáncer Colorrectal Julieta D’Annunzio 20 min Policy Scorecards: Hallazgos en América Latina Ana Rita González 30 min Kit de Herramientas Desarrollado por Global Colon Cancer Association (GCCA) Andrew Spiegel & Nicole Sheahan 20 min Preguntas y Encuesta Isabella Grueso CONFIDENTIALITY NOTICE: This e-mail and any files transmitted with it are confidential and intended solely for the use of the individual or entity to which it is addressed. If you have received this e-mail in error, you must not copy, distribute or take any action in reliance on it. Please notify the sender by e-mail or telephone. We utilize an anti-virus system and therefore any files sent via e-mail will have been checked for known viruses. You are however advised to run your own virus check before opening any attachments received as we will not in any event accept any liability whatsoever once an e-mail and/or any attachment is received. Any views expressed by an individual within this e-mail do not necessarily reflect the views of Pfizer, Inc. or any of its subsidiary companies.